respiratori
virus
major
caus
influenzalik
ill
ili
symptom
children
adult
lead
substanti
morbid
mortal
year
complic
ili
symptom
may
occur
young
children
year
old
elderli
peopl
year
old
even
though
ili
symptom
often
selflimit
restrain
upper
respiratori
tract
ili
symptom
character
sudden
onset
symptom
high
fever
cough
absenc
diagnosi
symptom
includ
myalgia
headach
chill
fatigu
use
option
inclus
criteria
although
known
rhinoviru
infect
caus
upper
respiratori
tract
infect
coronaviru
parainfluenza
viru
adenoviru
echoviru
coxsackieviru
account
remaind
case
virus
produc
clinic
indistinguish
diseas
make
specif
viral
diagnosi
difficult
mani
patient
use
complementari
altern
medicin
cam
therapi
treat
prevent
acut
respiratori
ill
worldwid
moreov
physician
familiar
efficaci
safeti
ginseng
tradit
use
asia
thousand
year
treat
varieti
ailment
put
activ
compound
deriv
ginseng
root
process
ginsenosid
saponin
glycosid
watersolubl
poli
oligosaccharid
variou
studi
shown
famili
compound
modul
variou
paramet
immun
respons
vitro
vivo
clinic
trial
healthi
subject
consum
standard
ginseng
extract
lower
incid
influenza
cold
higher
antibodi
titer
higher
natur
killer
cell
activ
well
increas
number
total
lymphocyt
helper
cell
ginseng
polysaccharid
prepar
increas
cytokin
product
mrna
express
murin
macrophag
spleen
cell
vitro
current
ginseng
well
known
effect
improv
qualityoflif
immunomodul
effect
howev
data
korean
red
ginseng
krg
accumul
prevent
activ
ili
onset
shown
american
ginseng
purpos
studi
evalu
efficaci
krg
extract
reduc
frequenc
sever
durat
ili
symptom
healthi
adult
evalu
efficaci
krg
extract
frequenc
ili
onset
healthi
subject
week
consumpt
evalu
follow
factor
healthi
subject
week
consumpt
sever
ili
symptom
b
durat
ili
symptom
studi
protocol
written
inform
consent
approv
function
food
institut
review
board
chonbuk
nation
univers
hospit
cuh
irb
subject
notifi
regard
studi
protocol
written
inform
consent
obtain
subject
studi
random
doubleblind
placebocontrol
twoarm
parallel
clinic
trial
compar
krg
extract
placebo
design
studi
integr
rigor
accord
principl
set
declar
helsinki
good
clinic
practic
guidelin
studi
plan
summar
figur
subject
includ
meet
follow
criteria
healthi
volunt
age
year
b
abil
give
inform
consent
exclus
criteria
studi
influenza
vaccin
subject
b
hiv
infect
cancer
patient
c
cardiovascular
diseas
neurolog
psychiatr
diseas
renal
pulmonari
hepat
abnorm
upper
respiratori
infect
within
two
week
studi
e
histori
diseas
could
interfer
test
product
imped
absorpt
gastrointestin
diseas
crohn
diseas
gastrointestin
surgeri
caesum
enterocel
surgeri
includ
f
take
medic
immunosuppress
drug
corticosteroid
warfarin
phenalzin
pentobarbit
haloperidol
cyclosporin
g
allerg
hypersensit
ginseng
h
laboratori
test
medic
psycholog
condit
deem
investig
interfer
success
particip
studi
histori
drug
alcohol
abus
prior
month
subject
recruit
local
advertis
doctor
referr
hospit
outpati
gener
practic
clinic
interest
subject
telephon
email
trial
coordin
trial
conduct
site
inform
subject
inform
consent
form
sent
interest
individu
read
prior
schedul
first
visit
enrol
subject
randomli
assign
one
two
group
either
krg
group
placebo
group
alloc
ratio
block
random
perform
site
remot
trial
locat
random
number
gener
computer
randomnumb
gener
blockrandom
method
softwar
program
excel
microsoft
offic
sequenc
gener
time
random
subject
draw
envelop
envelop
contain
number
conceal
treatment
alloc
random
sequenc
alloc
conceal
studi
subject
research
staff
investig
pharmacist
complet
studi
alloc
list
protect
password
access
file
held
noninvestig
independ
event
emerg
medic
situat
individu
random
code
group
alloc
identifi
primari
outcom
frequenc
ili
symptom
onset
subject
ask
openend
question
frequenc
ili
onset
studi
period
frequenc
ili
onset
check
weekli
via
telephon
secondari
outcom
varieti
ili
symptom
includ
fever
rhinorrhea
nasal
congest
sore
throat
cough
sputum
dyspnea
diarrhea
mawkish
vomit
headach
myalgia
sever
ili
symptom
durat
ili
symptom
outcom
check
weekli
via
telephon
schedul
assess
present
tabl
subject
ask
record
experienc
follow
symptom
sore
throat
runni
nose
nasal
congest
sneez
hoars
myalgia
earach
fever
headach
cough
tabl
selfassess
subject
record
number
day
experienc
symptom
subject
contact
telephon
week
report
ili
symptom
assur
complianc
studi
protocol
also
ask
record
studi
medic
help
shorten
durat
symptom
list
addit
medic
taken
symptom
subject
record
daili
symptom
sever
journal
use
sever
score
index
symptom
mild
symptom
moder
symptom
sever
symptom
effect
krg
extract
placebo
treatment
frequenc
sever
durat
symptom
relat
ili
prior
onset
influenza
season
analyz
pearson
chisquar
test
fisher
exact
test
minimum
expect
count
less
ratio
expect
count
lower
use
compar
proport
subject
report
symptom
relat
ili
advers
event
data
analyz
subject
randomli
assign
group
exclud
provid
baselin
inform
intentiontotreat
perprotocol
analysi
perform
subset
subject
report
ilirel
symptom
total
score
sever
durat
symptom
report
two
group
compar
use
mann
whitney
u
test
two
group
valu
p
consid
statist
signific
unexpect
advers
event
relat
krg
intak
report
investig
subject
write
individu
case
report
form
investig
safeti
assess
report
clinic
laboratori
test
vital
sign
measur
advers
event
clinic
laboratori
test
includ
astalt
buncreatinin
red
blood
cell
rbc
count
white
blood
cell
wbc
count
hemoglobin
hematocrit
number
platelet
number
differenti
cell
determin
week
baselin
end
trial
vital
sign
subject
check
monitor
advers
event
nauseavomit
fatigu
allerg
reaction
advers
event
relat
krg
extract
intak
visit
krg
soft
capsul
remain
visit
quantifi
order
enhanc
medic
complianc
subject
whose
complianc
krg
extract
capsul
total
dose
consid
droppedout
pilot
studi
first
clinic
trial
use
krg
extract
korean
popul
limit
inform
prevent
influenza
incid
symptom
releas
therefor
design
preliminari
test
use
total
particip
studi
examin
whether
krg
extract
administr
significantli
reduc
frequenc
sever
durat
ili
symptom
dose
krg
taken
time
daili
subject
week
initi
ili
symptom
confirm
collabor
physician
screen
visit
selfreport
ili
symptom
relief
symptom
confirm
within
day
subject
selfreport
recoveri
subject
record
daili
symptom
sever
journal
use
sever
score
aim
studi
evalu
efficaci
krg
extract
frequenc
sever
durat
ili
symptom
purpos
abil
krg
extract
reduc
ili
incid
assess
healthi
volunt
studi
expect
krg
extract
effect
reduc
ili
incid
studi
assess
rel
potenc
ginseng
extract
evalu
abil
prevent
upper
respiratori
tract
infect
ginseng
extract
studi
recent
rct
prevent
common
cold
flu
upper
respiratori
infect
two
studi
show
differ
ginseng
extract
placebo
term
decreas
durat
sever
frequenc
overal
symptom
one
studi
demonstr
ginseng
extract
decreas
durat
sever
frequenc
symptom
best
knowledg
report
demonstr
prevent
efficaci
krg
extract
ili
incid
therefor
studi
success
perform
krg
extract
may
offer
benefici
effect
reduc
ili
incid
result
appli
children
elderli
popul
draw
confirm
conclus
prevent
efficaci
safeti
krg
extract
ili
incid
fullscal
rct
conduct
conclus
near
futur
would
like
publish
later
author
declar
compet
interest
dyk
swc
kmc
kch
mgk
csl
receiv
research
fund
led
entir
studi
draft
manuscript
mro
ekc
hib
syk
eop
jhl
hji
mjk
hjk
particip
design
studi
perform
statist
analysi
author
read
approv
final
manuscript
prepubl
histori
paper
access
http
